RSV drug Beyfortus gets FDA approval for babies, toddlers
The monoclonal antibody, called Beyfortus, is the first of its kind likely to be available beyond a small population of immunocompromised children.
Source: oklahoman.com
Page 42 - John Farley News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from John Farley. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In John Farley Today - Breaking & Trending Today
RSV antibody approved for infants | News
This fall, parents and pediatricians will have a new option to protect babies from a lung-attacking virus that is the leading cause of hospitalization in infants under a year old
Source: wfmz.com
FDA approves shot that protects infants and toddlers against RSV – NBC Bay Area
U.S. officials approved the first long-acting drug to protect babies and toddlers against RSV.
Source: nbcbayarea.com
FDA approves shot that protects infants and toddlers against RSV – NBC 5 Dallas-Fort Worth
U.S. officials approved the first long-acting drug to protect babies and toddlers against RSV.
Source: nbcdfw.com
RSV drug gets FDA approval to protect kids 2 and under ahead of cold season
The Food and Drug Administration approved Beyfortus, an injection for infants and children up to 2 years old who face increased risk of severe RSV.
Source: reviewjournal.com